Ligand Pharmaceuticals
LGND
#4262
Rank
NZ$4.67 B
Marketcap
NZ$385.47
Share price
-0.88%
Change (1 day)
115.73%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): NZ$0.27 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.26 Billion. , an increase over its 2024 earnings that were of NZ$9.4 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 NZ$0.27 B2848.57%
2024 NZ$9.4 M-91.37%
2023 NZ$0.10 B-7.59%
2022 NZ$0.11 B4%
2021 NZ$0.11 B296.42%
2020 NZ$28.61 M-97.97%
2019 NZ$1.41 B275.62%
2018 NZ$0.37 B237.48%
2017 NZ$0.11 B49.05%
2016 NZ$74.66 M55.41%
2015 NZ$48.04 M36.87%
2014 NZ$35.1 M29.59%
2013 NZ$27.08 M1309.35%
2012 NZ$1.92 M-43.97%
2011 NZ$3.43 M-113.19%
2010 -NZ$26.01 Million59.86%
2009 -NZ$16.27 Million-61.33%
2008 -NZ$42.08 Million-58.75%
2007 -NZ$0.11 Billion20.52%
2006 -NZ$84.63 Million81.27%
2005 -NZ$46.69 Million
2003 -NZ$32.51 Million-20.6%
2002 -NZ$40.94 Million4.38%
2001 -NZ$39.22 Million-48.83%
2000 -NZ$76.63 Million-19.74%
1999 -NZ$95.48 Million-19.06%
1998 -NZ$0.12 Billion126.71%
1997 -NZ$52.04 Million-5.83%
1996 -NZ$55.26 Million136.23%
1995 -NZ$23.39 Million-33.97%
1994 -NZ$35.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$56.86 B 20,399.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$17.27 B 6,126.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$43.60 B 15,620.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.21 B 5,384.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-NZ$0.86 Billion-408.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$38.00 B 13,599.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$15.80 B 5,599.10%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$16.77 B 5,945.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-NZ$0.11 Billion-137.81%๐Ÿ‡บ๐Ÿ‡ธ USA